At a glance
ClinicalIndex Comparison RecordN/ACompleted· 129 enrolled
Drug / intervention
Axonics Sacral Neuromodulation System (SNM) Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt (ARTISAN-SNM)
In Brief
A clinical study evaluating Axonics Sacral Neuromodulation System (SNM) System for Urinary Incontinence, Urge. Completed, enrolled 129 participants across 4 sites in 3 countries.
Detailed Summary
The ARTISAN-SNM study is designed to evaluate the safety and effectiveness of the Axonics Sacral Neuromodulation System as an aid in the treatment of the symptoms of urinary urgency incontinence (UUI) in patients who have failed or could not tolerate more conservative treatments.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUrinary Incontinence, Urge
CountriesNetherlands, United Kingdom, United States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedNov 2017
Enrollment StartNov 2017
Primary CompletionJan 2019
Study CompletionJun 2020
TodayJul 2026
First PostedNov 1, 2017
Enrollment StartNov 21, 2017
Primary CompletionJan 18, 2019
Study CompletionJun 29, 2020
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 8.7 years ago
Interventions
Axonics Sacral Neuromodulation System (SNM) Systemdevice
Axonics Sacral Neuromodulation System (SNM) System